Home › Funds › BVF INC/IL › GPCR
BVF INC/IL position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
BVF INC/IL reported holding 3,366,823 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$180.7M, representing 4.62% of its reported portfolio and ranking #6 among its reported holdings. BVF INC/IL has disclosed GPCR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BVF INC/IL's GPCR position evolved
BVF INC/IL first disclosed a stake in GPCR in Q3 2023 at 1,750,000 shares (US$88.2M). The position peaked in Q4 2025 at 3,479,022 shares, worth US$242.0M. Across 12 filings, BVF INC/IL increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 3,366,823 shares valued at US$180.7M — a reduction of -92,535 shares quarter over quarter.. Notable position changes include a 54% trim in Q4 2023 (shares rose 5% over the following quarter), a 206% increase in Q2 2024 (shares rose 12% over the following quarter), a 81% increase in Q3 2025 (shares rose 148% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.75M | $88.23M | New |
| Q4 2023 | 812.99K | $33.14M | Reduce |
| Q1 2024 | 812.99K | $34.84M | Hold |
| Q2 2024 | 2.49M | $97.69M | Add |
| Q3 2024 | 2.24M | $98.27M | Reduce |
| Q4 2024 | 1.77M | $48.04M | Reduce |
| Q1 2025 | 1.77M | $30.66M | Hold |
| Q2 2025 | 1.77M | $36.74M | Hold |
| Q3 2025 | 3.20M | $89.71M | Add |
| Q4 2025 | 3.48M | $241.97M | Add |
| Q1 2026 | 3.46M | $166.74M | Reduce |
| Q2 2026 | 3.37M | $180.70M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPCR and 13F data
GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), ORBIMED ADVISORS LLC (US$118.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPCR
- Avoro Capital Advisors LLC 6.56M sh · $351.84M · Q2 2026
- Deep Track Capital, LP 4.74M sh · $254.40M · Q2 2026
- ORBIMED ADVISORS LLC 2.21M sh · $118.58M · Q2 2026
- RTW INVESTMENTS, LP 1.61M sh · $86.27M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M sh · $76.88M · Q2 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M sh · $58.29M · Q2 2026
- Siren, L.L.C. 872.97K sh · $46.85M · Q2 2026
- PACIFIC HEIGHTS ASSET MANAGEMENT LLC 800.00K sh · $42.94M · Q2 2026
- Rock Springs Capital Management LP 640.32K sh · $34.37M · Q2 2026
- Logos Global Management LP 500.00K sh · $26.84M · Q2 2026
- Parkman Healthcare Partners LLC 485.66K sh · $26.07M · Q2 2026
FAQ
How long has BVF INC/IL held GPCR?
BVF INC/IL has disclosed GPCR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BVF INC/IL's current position in GPCR?
As of Q2 2026, BVF INC/IL holds 3.37M shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $180.70M, representing 4.62% of its reported portfolio and ranking #6.
Has BVF INC/IL been buying or selling GPCR?
In the latest 13F filing (Q2 2026), BVF INC/IL reduced its position in GPCR. The position peaked in Q4 2025 at 3.48M shares.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, ORBIMED ADVISORS LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.